Skip to main content
Elekta logo

Elekta — Investor Relations & Filings

Ticker · EKTA ISIN · SE0000163628 LEI · 54930044O54BK617EP80 ST Manufacturing
Open in API
Filings indexed 1,124 across all filing types
Latest filing 2015-01-13 Regulatory Filings
Country SE Sweden
Listing ST EKTA

About Elekta

https://www.elekta.com/

Elekta is a company specializing in precision radiation medicine. It develops and provides clinical solutions, including equipment and software, for treating cancer and brain disorders. The company's portfolio features linear accelerators, the Elekta Unity MR-Linac system, Leksell Gamma Knife for stereotactic radiosurgery, and comprehensive brachytherapy solutions. Elekta also offers oncology informatics software to support treatment planning and clinical workflow. A key focus is advancing adaptive radiotherapy, a personalized approach that utilizes real-time imaging to precisely target tumors and minimize exposure to healthy tissue, aiming to improve patient outcomes.

Recent filings

Filing Released Lang Actions
Reminder: Welcome to an Elekta R&D update at University Medical Center Utrecht
Regulatory Filings Classification · 1% confidence The document is an announcement titled 'Reminder: Welcome to an Elekta R&D update' scheduled for a specific date and location. It details the agenda, speakers (CEO, VPs, and external professors), and provides instructions for attendance (RSVP, phone/web dial-in details). This is not a formal regulatory filing like a 10-K or IR, nor is it a transcript of a call that has already happened. It is an invitation/notice about an upcoming investor/analyst event focused on R&D and a specific project (MRI guided therapy). This type of event announcement, which is informational for investors but not a core financial report, best fits the 'Investor Presentation' (IP) category if it were the presentation itself, or potentially a general 'Regulatory Filing' (RNS) if it were a mandatory disclosure of an event. However, since it is explicitly inviting stakeholders to an 'update' event where presentations will occur, it functions as a precursor or announcement related to investor relations activities. Given the options, and recognizing it's an announcement about an event where information will be shared, it is most closely related to investor communication. Since it is not a formal earnings release (ER) or a standard proxy/AGM material, and it is an announcement about an event, it is often classified under general investor communications. In this context, where the content is an invitation to an R&D update event, it is most analogous to an announcement preceding an Investor Presentation (IP) or a general investor relations communication. Given the specific definitions, it doesn't perfectly match any, but it is an announcement about an event where investors/analysts are invited to hear updates. If the event itself were a standard earnings call, it would be CT. Since it's an R&D update, it's an investor-focused event. I will classify this as an Investor Presentation (IP) announcement, as it sets the stage for the information to be presented, or RNS as a general disclosure. Given the nature of the content (detailed update on R&D/product pipeline for investors), IP is a strong candidate if we interpret it as the material *leading up to* the presentation, but RNS is safer for an event invitation that isn't a standard report. However, looking closely at the content—it's an invitation to an R&D update event, not a formal regulatory filing like a 10-K or a dividend notice. It is a specific communication aimed at investors/analysts about a future event. This type of announcement often falls under general investor relations disclosures. Since it is not a formal report, and it is an announcement, RNS is the most appropriate fallback for a specific, non-standard investor event invitation that doesn't fit ER, CT, or AGM-R.
2015-01-13 English
Welcome to an Elekta R&D update at University Medical Center Utrecht
Report Publication Announcement Classification · 1% confidence The document is an announcement inviting investors, analysts, and media to an 'Elekta R&D update' event scheduled for January 22, 2015, focusing on MRI-guided radiation therapy (the Atlantic project). It details the speakers, location, and registration instructions. This is not a formal regulatory filing (like 10-K, IR, ER), nor is it a transcript of a call (CT). It is an announcement about a specific informational event aimed at investors and analysts regarding R&D progress, which aligns best with an Investor Presentation (IP) or a general corporate update. Since it is an invitation to an update event where presentations will be given, 'Investor Presentation' (IP) is the most fitting category, as these updates often serve as informal investor briefings, even if the presentation itself is delivered later. It is not a formal 'Report Publication Announcement' (RPA) because it announces an event, not the publication of a periodic report.
2014-12-22 English
Välkommen till Elektas FoU-uppdatering vid University Medical Center Utrecht
Regulatory Filings Classification · 1% confidence The document is an announcement inviting investors, analysts, and media to an R&D update focusing on Project Atlantic (MRI-guided radiation therapy) scheduled for January 22, 2015. It details the speakers (CEO, VPs, and external professors) and the topics to be covered, including R&D investments and milestones for an MRI-guided linear accelerator. This is not a formal financial report (like 10-K or IR), nor is it a transcript (CT) or a standard earnings release (ER). It is an invitation and agenda for a specific event aimed at investors to discuss strategy and development, which aligns best with an Investor Presentation (IP) or a general announcement about an investor-focused event. Given the context of presenting R&D strategy and future milestones to investors, 'Investor Presentation' (IP) is the most fitting category, even though it's an announcement *for* the presentation, as the content is presentation-focused.
2014-12-22 Swedish
Avera Health samarbetar med Elekta för avancerad cancervård
Regulatory Filings Classification · 1% confidence The document is a press release written in Swedish announcing a strategic partnership between Avera Health and Elekta regarding advanced cancer care technology implementation. It details the scope of the agreement, the equipment involved, and includes quotes from executives. Crucially, it concludes with contact information for Investor Relations and a statement indicating that the information is being made public according to financial market laws ('Informationen är sådan som Elekta AB (publ) ska offentliggöra enligt lagen om handel med finansiella instrument och/eller lagen om värdepappersmarknaden. Informationen lämnades för offentliggörande den 4 december 2014 kl. 07.30 CET.'). This structure strongly suggests a formal regulatory disclosure or an announcement intended for investors regarding a significant business event, rather than a full financial report (10-K, IR) or a simple dividend/share transaction notice. Since it is a general announcement of a material business development that doesn't fit perfectly into CAP (financing) or TAR (M&A), the most appropriate general category for significant, non-standard regulatory news is 'Regulatory Filings' (RNS), which serves as a broad category for official company announcements not covered elsewhere.
2014-12-04 Swedish
Avera Health partners with Elekta to deliver most advanced cancer care
M&A Activity Classification · 1% confidence The document announces a strategic partnership between Avera Health and Elekta regarding the deployment of oncology information systems and equipment. It includes quotes from executives, details about the technology involved, and a financial note that "More than USD 20 million of the agreement was booked during Elekta's second fiscal quarter." The text concludes with boilerplate information about Elekta and Avera Health, and a statement that the information is being made public according to securities laws. This content strongly suggests a material business development announcement, likely related to financing/capital expenditure or a significant operational agreement. Since it is not a formal regulatory report (like 10-K, IR, or ER), and it details a major business transaction/agreement, it fits best under 'Capital/Financing Update' (CAP) if the focus is on the financial commitment, or potentially 'Regulatory Filings' (RNS) as a general announcement. Given the explicit mention of a multi-million dollar booking related to the agreement, 'CAP' is a strong candidate, but often these types of press releases announcing major contracts are classified broadly. However, looking at the definitions, none perfectly capture a 'Partnership Announcement' or 'Business Update'. Since it is a formal announcement of a significant business event that involves a financial booking, and it is not a standard financial report, it is most appropriately classified as a general 'Regulatory Filing' (RNS) if a more specific category like M&A (TAR) does not apply, or if it is a general press release disclosure. Since it is not a standard financial report, and it is not about M&A, the best fit among the provided options for a general, material business announcement that doesn't fit elsewhere is RNS, although it shares characteristics with CAP (financing/capital deployment). Given the context of a press release format disclosing a major contract, RNS (Regulatory Filings/General Announcement) is the safest fallback for non-standard disclosures.
2014-12-04 English
Elekta Ltd and Medical Intelligence Medizintechnik GmbH defend claims by humediQ GmbH
Legal Proceedings Report Classification · 1% confidence The document text explicitly details a legal dispute where humediQ GmbH has initiated legal proceedings against Elekta group companies, claiming damages of approximately EUR 16 million related to an exclusive supply agreement. This content directly relates to significant lawsuits or regulatory actions involving the company. Based on the provided definitions, this aligns perfectly with the 'Legal Proceedings Report' (LTR) category.
2014-12-02 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.